Merkel cell carcinoma: An algorithm for multidisciplinary management and decision-making

Crit Rev Oncol Hematol. 2016 Feb:98:170-9. doi: 10.1016/j.critrevonc.2015.10.008. Epub 2015 Nov 10.

Abstract

Merkel cell carcinoma (MCC) is a rare and aggressive neuroendocrine tumor of the skin. Therapeutic approach is often unclear, and considerable controversy exists regarding MCC pathogenesis and optimal management. Due to its rising incidence and poor prognosis, it is imperative to establish the optimal therapy for both the tumor and the lymph node basin, and for treatment to include sentinel node biopsy. Sentinel node biopsy is currently the most consistent predictor of survival for MCC patients, although there are conflicting views and a lack of awareness regarding node management. Tumor and node management involve different specialists, and their respective decisions and interventions are interrelated. No effective systemic treatment has been made available to date, and therefore patients continue to experience distant failure, often without local failure. This review aims to improve multidisciplinary decision-making by presenting scientific evidence of the contributions of each team member implicated in MCC management. Following this review of previously published research, the authors conclude that multidisciplinary team management is beneficial for care, and propose a multidisciplinary decision algorithm for managing this tumor.

Keywords: Algorithm for treatment; Decision making; Merkel cell carcinoma; Multidisciplinar management.

Publication types

  • Review

MeSH terms

  • Algorithms*
  • Carcinoma, Merkel Cell / therapy*
  • Combined Modality Therapy / methods*
  • Decision Making*
  • Humans
  • Interdisciplinary Communication*
  • Lymph Nodes / pathology
  • Neuroendocrine Tumors / therapy
  • Patient Care Team
  • Sentinel Lymph Node Biopsy
  • Skin / pathology
  • Skin Neoplasms / therapy*
  • Treatment Outcome